Improving ferroptosis-mediated immunotherapy for colorectal cancer through lysosome-targeted photodynamic therapy
Materials Today Bio · 2025-04 · 31 · 101552
DOI: 10.1016/j.mtbio.2025.101552 ↗Kurz gefasst
Fachartikel in der Zeitschrift Materials Today Bio, 2025-04. Verfasst von Zhian Chen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Zhongshan City People's Hospital, Zhongshan, 528403, China. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Southern Medical University, Guangdong Medical Research Foundation, Guangdong Provincial Natural Science Foundation.
Abstract (Originalsprache)
Lysosomes is emerging as a promising therapeutic target for improving immunotherapy, which dysfunction would trigger lysosomal membrane permeabilization increase and subsequent leakage of reduced iron, which contributed to ferroptosis through cell-intrinsic Fenton chemistry. However, the integrity of lysosomal membranes is not susceptible to disrupt, owing to the presence of several Endo-lysosomal damage-response mechanisms. Herein, we developed a lysosome-targeted photosensitizer (TLA), which possessed robust light stability, good bio-compatibility, and high photodynamic therapy (PDT) effect. Upon internalized by cancer cells, TLA was specifically accumulated in lysosome, and which would destroy the integrity of lysosomal membranes and inhibit protective autophagy upon exposure to light irradiation. Subsequently, the cancer cells were suffered from ferroptosis through triggering cell-intrinsic Fenton chemistry and mitochondrial dysfunction, which would release damage-associated molecular pattern molecules (DAMPs) to induce immunogenic cell death and remodel immunosuppressive tumor microenvironment. Notably, combined with PD-L1 antibody and TLA could greatly potentiate the immune response and exhibit highest anti-tumor effects. In summary, this novel lysosome-targeted photosensitizer could serve as a promising strategy for the treatment of colorectal cancer.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Zhongshan City People's Hospital, Zhongshan, 528403, China.
- The First School of Clinical Medicine, Southern Medical University, Guangzhou, 510515, China.
- State Key Laboratory of Organ Failure Research, Guangdong Provincial Key Laboratory of Viral Hepatitis Research, Department of Hepatology Unit and Infectious Diseases, Nanfang Hospital, Southern Medical University, Guan…
- Cancer Research Institute, School of Basic Medical Sciences, Southern Medical University, Guangzhou, Guangdong, 510515, China.
- Department of Cardiology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China.
- Breast Center, Department of General Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Förderung
- Southern Medical University
- Guangdong Medical Research Foundation
- Guangdong Provincial Natural Science Foundation
Zitieren
APA
Chen, Z., Wang, Y., Li, Z., Chen, M., Li, Y., Lu, C., Lin, Z., Zheng, H., Chen, L., & Zhang, Q. (2025). Improving ferroptosis-mediated immunotherapy for colorectal cancer through lysosome-targeted photodynamic therapy. Materials Today Bio, 31, 101552. https://doi.org/10.1016/j.mtbio.2025.101552
Vancouver
Chen Z, Wang Y, Li Z, Chen M, Li Y, Lu C, et al. Improving ferroptosis-mediated immunotherapy for colorectal cancer through lysosome-targeted photodynamic therapy. Materials Today Bio. 2025;31:101552. doi:10.1016/j.mtbio.2025.101552
BibTeX
@article{Chen2025,
author = {Chen, Zhian and Wang, Yutong and Li, Zhenhao and Chen, Meijuan and Li, Yingshi and Lu, Chuyue and Lin, Zhenyu and Zheng, Hua and Chen, Lujia and Zhang, Qianbing},
title = {Improving ferroptosis-mediated immunotherapy for colorectal cancer through lysosome-targeted photodynamic therapy},
journal = {Materials Today Bio},
year = {2025},
volume = {31},
pages = {101552},
doi = {10.1016/j.mtbio.2025.101552}
}
EUVIMED